Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease

被引:42
作者
Ciotti, M
Chen, F
Rubaltelli, FF
Owens, IS
机构
[1] NICHHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA
[2] Univ Florence, Cattedra Neonatol, I-50134 Florence, Italy
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 1998年 / 1407卷 / 01期
关键词
Crigler-Najjar types I and II; bilirubin UDP-glucuronosyltransferase activity and gene; TATA box mutation; compound heterozygotes;
D O I
10.1016/S0925-4439(98)00030-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations at the bilirubin UDP-glucuronosyltransferase (transferase) gene in a severely hyperbilirubinemic Crigler-Najjar (CN) type I individual was compared with that in a moderately hyperbilirubinemic CN II individual. The CN-I (CF) patient in this study sustained a TATA box insertional mutation which was paired with a coding defect at the second allele, unlike all coding defects previously seen in CN-I patients. The sequence of the mutant TATA box, [A(TA)(8)A], also seen in the CN-II patient, was compared with that at the wild-type box, [A(TA) IA]. Transcriptional activity with [A(TA)(8)A] was 10-15% that with the wild-type box when present in the -1.7 kb upstream regulatory region (URR) of the bilirubin transferase UGT1A1 gene which was fused to the chloramphenicol acetyl transferase reporter gene, pCAT 1.7H, and transfected into HepG2 cells. Also, a construct with a TA deletion, [A(TA)(6)A], was prepared and used as a control; transcriptional activity was 65% normal. The coding region defect, R336W, seen in CF (CN-I) was placed in the bilirubin transferase UGT1A1 [HUG-Brl] cDNA, and its corresponding protein was designated UGT1A1*32. The UGT1A1*32 protein supported 0-10% normal bilirubin glucuronidation when expressed in COS-1 cells. The I294T coding defect seen at the second allele in SM (CN-II) generated the UGT1A1*33 mutant protein which supported 40-55% normal activity with a normal K-m (2.5 mu M) for bilirubin. The hyperbilirubinemia seen in SM decreased in response to phenobarbital treatment, unlike that seen in CF. Parents of the patients were carriers of the respective mutations uncovered in the offspring. The TATA box mutation paired with a deleterious missense mutation is, therefore, completely repressive in the CN-I patient, and is responsible for a lethal genotype/phenotype; but when homozygous, i.e. paired with itself, as previously reported in the literature, it is far less repressive and generates the mild Gilbert's phenotype. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:40 / 50
页数:11
相关论文
共 32 条
  • [1] ANALYSIS OF GENES FOR BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE IN GILBERTS-SYNDROME
    AONO, S
    ADACHI, Y
    UYAMA, E
    YAMADA, Y
    KEINO, H
    NANNO, T
    KOIWAI, O
    SATO, H
    [J]. LANCET, 1995, 345 (8955): : 958 - 959
  • [2] IDENTIFICATION OF DEFECT IN THE GENES FOR BILIRUBIN UDP-GLUCURONOSYL-TRANSFERASE IN A PATIENT WITH CRIGLER-NAJJAR SYNDROME TYPE-II
    AONO, S
    YAMADA, Y
    KEINO, H
    HANADA, N
    NAKAGAWA, T
    SASAOKA, Y
    YAZAWA, T
    SATO, H
    KOIWAI, O
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (03) : 1239 - 1244
  • [3] CHRONIC NONHEMOLYTIC UNCONJUGATED HYPERBILIRUBINEMIA WITH GLUCURONYL TRANSFERASE DEFICIENCY - CLINICAL, BIOCHEMICAL, PHARMACOLOGIC AND GENETIC EVIDENCE FOR HETEROGENEITY
    ARIAS, IM
    GARTNER, LM
    COHEN, M
    EZZER, JB
    LEVI, AJ
    [J]. AMERICAN JOURNAL OF MEDICINE, 1969, 47 (03) : 395 - &
  • [4] HEPATIC BILIRUBIN UDP-GLUCURONYL TRANSFERASE ACTIVITY IN LIVER DISEASE AND GILBERTS SYNDROME
    BLACK, M
    BILLING, BH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (23) : 1266 - &
  • [5] BLACK M, 1970, LANCET, V1, P1359
  • [6] A MUTATION IN BILIRUBIN URIDINE 5'-DIPHOSPHATE-GLUCURONOSYLTRANSFERASE ISOFORM-1 CAUSING CRIGLER-NAJJAR SYNDROME TYPE-II
    BOSMA, PJ
    GOLDHOORN, B
    ELFERINK, RPJO
    SINAASAPPEL, M
    OOSTRA, BA
    JANSEN, PLM
    [J]. GASTROENTEROLOGY, 1993, 105 (01) : 216 - 220
  • [7] MECHANISMS OF INHERITED DEFICIENCIES OF MULTIPLE UDP-GLUCURONOSYLTRANSFERASE ISOFORMS IN 2 PATIENTS WITH CRIGLER-NAJJAR SYNDROME, TYPE-I
    BOSMA, PJ
    CHOWDHURY, JR
    HUANG, TJ
    LAHIRI, P
    ELFERINK, RPJO
    VANES, HHG
    LEDERSTEIN, M
    WHITINGTON, PF
    JANSEN, PLM
    CHOWDHURY, NR
    [J]. FASEB JOURNAL, 1992, 6 (10) : 2859 - 2863
  • [8] THE GENETIC-BASIS OF THE REDUCED EXPRESSION OF BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE-1 IN GILBERTS-SYNDROME
    BOSMA, PJ
    CHOWDHURY, JR
    BAKKER, C
    GANTLA, S
    DEBOER, A
    OOSTRA, BA
    LINDHOUT, D
    TYTGAT, GNJ
    JANSEN, PLM
    ELFERINK, RPJO
    CHOWDHURY, NR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (18) : 1171 - 1175
  • [9] CHEN CA, 1988, BIOTECHNIQUES, V6, P632
  • [10] ALTERED CODING FOR A STRICTLY CONSERVED DI-GLYCINE IN THE MAJOR BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE OF A CRIGLER-NAJJAR TYPE-I PATIENT
    CIOTTI, M
    YEATMAN, MT
    SOKOL, RJ
    OWENS, IS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (07) : 3284 - 3291